<p><strong>ACM Research, Inc.</strong>（納斯達克代碼：ACMR）的股價在過去 30 天內大幅下跌了 28%，回吐了近期的許多漲幅。不過，糟糕的一個月並沒有完全毀掉過去一年，股價上漲了 63%，即使在牛市中也表現出色。</p>
<p>即使在如此大幅的價格下跌之後，你仍然可以對 ACM Research 的市盈率 16.6 倍感到無所謂，因為美國的市盈率中位數也接近 18 倍。不過，簡單忽視市盈率而不加解釋並不明智，因為投資者可能會忽略一個明顯的機會或一個代價高昂的錯誤。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>最近一段時間對 ACM Research 來説是有利的，因為其收益增長速度超過了大多數其他公司。許多人可能預計強勁的收益表現會減弱，這使得市盈率未能上升。如果不是這樣，那麼現有股東有理由對股價未來的走勢感到樂觀。</p>
<p>查看我們對 ACM Research 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247"/></p>
<p>納斯達克 GM:ACMR 市盈率與行業比較 2025 年 11 月 24 日</p>
<p>想要了解分析師對公司的完整估計嗎？那麼我們 <strong>免費的</strong>ACM Research 報告將幫助你揭示未來的趨勢。</p>
<h2>增長是否與市盈率匹配？</h2>
<p>ACM Research 的市盈率對於一家僅預期實現適度增長的公司來説是典型的，重要的是，它的表現與市場保持一致。</p>
<p>如果我們回顧過去一年的收益增長，公司實現了 26% 的顯著增長。最近三年期間，EPS 也整體上升了 148%，得益於其短期表現。因此，可以公平地説，最近的收益增長對公司來説是非常出色的。</p>
<p>展望未來，覆蓋該公司的九位分析師的估計表明，未來三年每年的收益應增長 16%。這將顯著高於更廣泛市場預期的每年 11% 的增長。</p>
<p>考慮到這一點，令人好奇的是，ACM Research 的市盈率與大多數其他公司相當。顯然，一些股東對預測持懷疑態度，並接受了較低的出售價格。</p>
<h2>ACM Research 市盈率的底線</h2>
<p>隨着股價下跌，ACM Research 的市盈率現在看起來相當普通。通常，我們的偏好是將市盈率的使用限制在確定市場對公司整體健康狀況的看法上。</p>
<p>我們已經確定，ACM Research 目前的市盈率低於預期，因為其預測增長高於更廣泛的市場。當我們看到強勁的收益前景與快於市場的增長時，我們假設潛在風險可能是對市盈率施加壓力的原因。至少價格下跌的風險看起來是被抑制的，但投資者似乎認為未來的收益可能會出現一些波動。</p>
<p>許多潛在風險可能存在於公司的資產負債表中。你可以通過我們 <strong>免費的</strong>ACM Research 資產負債表分析進行六項簡單檢查來評估許多主要風險。</p>
<p><strong>如果你對市盈率感興趣</strong>，你可能希望查看這份 <strong>免費的</strong> 其他強勁收益增長和低市盈率公司的集合。</p>

ACMR

<p>ACM Research, Inc.（納斯達克代碼：ACMR）在過去 30 天內股價下跌了 28%，儘管過去一年上漲了 63%。其市盈率為 16.6 倍，接近美國中位數的 18 倍，暗示着適度的增長預期。公司的收益增長速度超過大多數公司，去年增長了 26%，三年內增長了 148%。分析師預測年均增長為 16%，高於市場的 11%。儘管收益前景強勁，但仍存在懷疑情緒，影響了市盈率</p>

<p>The <strong>ACM Research, Inc.</strong> (NASDAQ:ACMR) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately. Still, a bad month hasn't completely ruined the past year with the stock gaining 63%, which is great even in a bull market.</p>
<div class="lb-trans"><p><strong>ACM Research, Inc.</strong>（納斯達克代碼：ACMR）的股價在過去 30 天內大幅下跌了 28%，回吐了近期的許多漲幅。不過，糟糕的一個月並沒有完全毀掉過去一年，股價上漲了 63%，即使在牛市中也表現出色。</p>
</div><p>Even after such a large drop in price, you could still be forgiven for feeling indifferent about ACM Research's P/E ratio of 16.6x, since the median price-to-earnings (or &#34;P/E&#34;) ratio in the United States is also close to 18x. Although, it's not wise to simply ignore the P/E without explanation as investors may be disregarding a distinct opportunity or a costly mistake.</p>
<div class="lb-trans"><p>即使在如此大幅的價格下跌之後，你仍然可以對 ACM Research 的市盈率 16.6 倍感到無所謂，因為美國的市盈率中位數也接近 18 倍。不過，簡單忽視市盈率而不加解釋並不明智，因為投資者可能會忽略一個明顯的機會或一個代價高昂的錯誤。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>Recent times have been advantageous for ACM Research as its earnings have been rising faster than most other companies. It might be that many expect the strong earnings performance to wane, which has kept the P/E from rising. If not, then existing shareholders have reason to be feeling optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>最近一段時間對 ACM Research 來説是有利的，因為其收益增長速度超過了大多數其他公司。許多人可能預計強勁的收益表現會減弱，這使得市盈率未能上升。如果不是這樣，那麼現有股東有理由對股價未來的走勢感到樂觀。</p>
</div><p>See our latest analysis for ACM Research</p>
<div class="lb-trans"><p>查看我們對 ACM Research 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247" alt="" original-src="https://images.simplywall.st/asset/chart/380776488-pe-multiple-vs-industry-1-dark-2/1763972622247"/></p>
<p>NasdaqGM:ACMR Price to Earnings Ratio vs Industry November 24th 2025</p>
<div class="lb-trans"><p>納斯達克 GM:ACMR 市盈率與行業比較 2025 年 11 月 24 日</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on ACM Research will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析師對公司的完整估計嗎？那麼我們 <strong>免費的</strong>ACM Research 報告將幫助你揭示未來的趨勢。</p>
</div><h2>Does Growth Match The P/E?</h2>
<div class="lb-trans"><h2>增長是否與市盈率匹配？</h2>
</div><p>ACM Research's P/E ratio would be typical for a company that's only expected to deliver moderate growth, and importantly, perform in line with the market.</p>
<div class="lb-trans"><p>ACM Research 的市盈率對於一家僅預期實現適度增長的公司來説是典型的，重要的是，它的表現與市場保持一致。</p>
</div><p>If we review the last year of earnings growth, the company posted a terrific increase of 26%. The latest three year period has also seen an excellent 148% overall rise in EPS, aided by its short-term performance. Therefore, it's fair to say the earnings growth recently has been superb for the company.</p>
<div class="lb-trans"><p>如果我們回顧過去一年的收益增長，公司實現了 26% 的顯著增長。最近三年期間，EPS 也整體上升了 148%，得益於其短期表現。因此，可以公平地説，最近的收益增長對公司來説是非常出色的。</p>
</div><p>Shifting to the future, estimates from the nine analysts covering the company suggest earnings should grow by 16% each year over the next three years. That's shaping up to be materially higher than the 11% per year growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未來，覆蓋該公司的九位分析師的估計表明，未來三年每年的收益應增長 16%。這將顯著高於更廣泛市場預期的每年 11% 的增長。</p>
</div><p>In light of this, it's curious that ACM Research's P/E sits in line with the majority of other companies. Apparently some shareholders are skeptical of the forecasts and have been accepting lower selling prices.</p>
<div class="lb-trans"><p>考慮到這一點，令人好奇的是，ACM Research 的市盈率與大多數其他公司相當。顯然，一些股東對預測持懷疑態度，並接受了較低的出售價格。</p>
</div><h2>The Bottom Line On ACM Research's P/E</h2>
<div class="lb-trans"><h2>ACM Research 市盈率的底線</h2>
</div><p>With its share price falling into a hole, the P/E for ACM Research looks quite average now. Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>隨着股價下跌，ACM Research 的市盈率現在看起來相當普通。通常，我們的偏好是將市盈率的使用限制在確定市場對公司整體健康狀況的看法上。</p>
</div><p>We've established that ACM Research currently trades on a lower than expected P/E since its forecast growth is higher than the wider market. When we see a strong earnings outlook with faster-than-market growth, we assume potential risks are what might be placing pressure on the P/E ratio. At least the risk of a price drop looks to be subdued, but investors seem to think future earnings could see some volatility.</p>
<div class="lb-trans"><p>我們已經確定，ACM Research 目前的市盈率低於預期，因為其預測增長高於更廣泛的市場。當我們看到強勁的收益前景與快於市場的增長時，我們假設潛在風險可能是對市盈率施加壓力的原因。至少價格下跌的風險看起來是被抑制的，但投資者似乎認為未來的收益可能會出現一些波動。</p>
</div><p>A lot of potential risks can sit within a company's balance sheet. You can assess many of the main risks through our <strong>free</strong> balance sheet analysis for ACM Research with six simple checks.</p>
<div class="lb-trans"><p>許多潛在風險可能存在於公司的資產負債表中。你可以通過我們 <strong>免費的</strong>ACM Research 資產負債表分析進行六項簡單檢查來評估許多主要風險。</p>
</div><p><strong>If P/E ratios interest you</strong>, you may wish to see this <strong>free</strong> collection of other companies with strong earnings growth and low P/E ratios.</p>
<div class="lb-trans"><p><strong>如果你對市盈率感興趣</strong>，你可能希望查看這份 <strong>免費的</strong> 其他強勁收益增長和低市盈率公司的集合。</p>
</div>

ACM Research, Inc. (NASDAQ:ACMR) 已下跌 28%，但其風險可能比表面上看起來更大